8th German Pharm-Tox Summit

Potential influence of cancer-patient derived mutations in the MAP kinase negative regulator DUSP2 (dual-specificity phosphatase 2) on phosphatase activity

Cancer pharmacology	

<B>Posters will be presented during the time period mentioned above. This will give all participants and the poster jury the opportunity to interact with the presenting authors. Please be available to answer questions at your poster during the poster session.  

Session 1

Poster

Pharmacogenomics and personalized medicine	

Mechanisms of drug resistance in chronic myeloid leukemia – The role of cell adhesion signaling and fibronectin 1

Cancer pharmacology and treatment

Oral presentation

Receptor tyrosine kinases

Role of fibronectin 1 in tyrosine kinase inhibitor resistance in chronic myeloid leukemia

Disease models, drug development

Short talks

Chair

H4/5

Drug-host-microbiome interactions in cardiometabolic disease

Plenary Lecture 

Welcome Note by the DGPT President 

TTU Hörsaal (M 28)

Opening

Welcome

Speaker

Grundlagen und klinische Implikationen von Arzneimittel-Interaktionen

Arzneimittelinteraktionen

Lecture

Prof. Dr. Dr.

Ingolf Cascorbi

Chair

Speaker

Further involvements